2021.08.18 – Clinical Assessment and Management of Spasticity following Brain Injury (Live Webinar)

A David Strauss Memorial Clinical Lecture live webinar featuring Cindy B. Ivanhoe, M.D. Airs live at 3 p.m. ET August 18, 2021. Registration closes at 11:59 p.m. ET August 17, 2021.

This webinar was created in partnership with Ipsen Biopharmaceuticals and provided at no cost to attendees.

We have met our registration limit for the live webinar. Please check our website on Sept. 1, 2021 for the webinar recording.

What are considerations in treating persons with brain injury? Join this David Strauss Memorial Clinical Lecture live webinar as Cindy B. Ivanhoe, M.D., discusses treatment goals and treatment options for individuals with spasticity.

Learning Objectives

  1. Identify goals of treating spasticity.
  2. Discuss pluses and minuses of treatment options.
  3. Understand the role of botulinum toxins in spasticity treatment.
  4. Discuss when to refer patients with brain injury for intrathecal baclofen therapy.

Includes 1 ACBIS CEU. If you purchase a registration, you will receive an email with attendance instructions the day the webinar airs. Please make sure to whitelist skelly@biausa.org to ensure you receive the instructions.

Dr. Ivanhoe is board certified in Physical Medicine and Rehabilitation and in Brain Injury Medicine. Dr. Ivanhoe did her clinical fellowship in Brain Injury and Stroke Rehabilitation through a government-funded grant to Baylor College of Medicine, centered at what was then the Institute for Rehabilitation and Research (TIRR) in the Texas Medical Center (now TIRR Memorial Hermann). Dr. Ivanhoe was co-director and then director of that Brain Injury and Stroke Program. Dr. Ivanhoe was a professor in the Baylor College of Medicine Department of Physical Medicine and Rehabilitation until her resignation, the summer of 2019. She is a clinical professor in the Department of Physical Medicine and Rehabilitation McGovern School of Medicine v. University of Texas Health Science Center at Houston. She is an admitting physician to the Brain Injury and Stroke Program at TIRR Memorial Hermann. Dr. Ivanhoe founded and served as Chief Medical Officer of a residential post-acute brain injury program until 2017; a program and philosophy of care conceptualized in her kitchen. She has served as faculty in courses across the US and abroad, and is most known for expertise in the treatment of spasticity and its role in functional recovery, medical complications of brain injury; at times, as an advocate for healthcare access. Her clinical experience has spanned the entire spectrum of brain injury from developmental disabilities, neurosurgical ICUs, and acute rehabilitation to long-term follow-up in the community. Her nonprofit, IF (Ivanhoe Foundation) supports endeavors that serve to improve the lives of those with brain injuries and other disabilities in the community. Dr. Ivanhoe is most known for pioneering the clinical use of interventions for spasticity including Intrathecal Baclofen therapy for which she was an investigator on the studies that led to its FDA approval, the use of botulinum toxins, and for teaching. She is published in articles and textbooks. Dr. Ivanhoe has served on the board of directors of the International Neurotoxin Association and their educational committees, as well as the board of Mentis Neuro Health until 2017. Dr. Ivanhoe is a member of speakers’ bureaus and/or advisory boards of companies involved in the treatment of spasticity and other aspects of the Upper Motor Neuron Syndrome. She is recognized by US News and World Report Best Doctors and Best Doctors in Texas and has received awards from the Brain Injury Association of Texas; American Congress of Rehabilitation Medicine; Baylor College of Medicine for her contributions to advocacy, teaching, and education; the service award from the CNS Council of the American Academy of Physical Medicine and Rehabilitation and the Distinguished Clinician Award by the American Academy of Physical Medicine and Rehabilitation. She was awarded the Humanitarian Award by the Brain Injury Alliance of Texas and has received the Professional Contribution and Lifetime Achievement Awards from the Brain Injury Association of Texas.

BIAA Webinar Cancellation and Refund Policy for Live Webinars

Registration cancellations must be emailed to customerservice@biausa.org. Refund Eligibility: Webinar registration fees are refundable if submitted no later than 24 hours before the scheduled webinar date/start time. Refunds are subject to a $10 cancellation fee. Cancellations received less than 24 hours before the scheduled webinar date/start time will not be refunded. If you are unable to attend the live webinar, you can request access to the recorded webinar. If we cancel a webinar due to circumstances beyond our control, we will notify attendees with as much advance notice as possible. Attendees will be given the opportunity to transfer their registration to another webinar or obtain a full refund.

Refunds are Not Provided for the Following Reasons: 1. Attendee Technology. It is the responsibility of the webinar attendee to test the computer setup prior to the start of the webinar. If failure with your technology prevents access to the live webinar, you will not be eligible for a refund. If the technical problem is due to our error, we will offer you the choice of access to a copy of the recording or a full refund. 2. Attendee Email. Refunds will not be issued in cases where an attendee did not receive the webinar login instruction email. It is the attendee’s responsibility to contact us if they don’t receive the required login information at least 24 hours prior to the start time of the webinar. 3. Attendee Absence. Attendees who do not participate in the live webinar will not be entitled to a refund.